Publisher
Springer Science and Business Media LLC
Subject
Molecular Biology,Applied Microbiology and Biotechnology,Biochemistry,General Medicine,Bioengineering,Biotechnology
Reference56 articles.
1. Doubeni, C. A., Doubeni, A. R., & Myers, A. E. (2016). Diagnosis and management of ovarian cancer. American Family Physician, 93(11), 937–944.
2. Bonadio, R. C., & Estevez-Diz, M. (2021). Perspectives on PARP inhibitor combinations for ovarian cancer. Frontiers in Oncology, 11, 754524. https://doi.org/10.3389/fonc.2021.754524
3. Curtin, N. J., & Szabo, C. (2020). Poly(ADP-ribose) polymerase inhibition: Past, present and future. Nature Reviews Drug Discovery, 19(10), 711–736. https://doi.org/10.1038/s41573-020-0076-6
4. Javle, M., & Curtin, N. J. (2011). The role of PARP in DNA repair and its therapeutic exploitation. British Journal of Cancer, 105(8), 1114–1122. https://doi.org/10.1038/bjc.2011.382
5. Hodgson, D. R., Dougherty, B. A., Lai, Z., Fielding, A., Grinsted, L., Spencer, S., O’Connor, M. J., Ho, T. W., Robertson, J. D., Lanchbury, J. S., Timms, K. M., Gutin, A., Orr, M., Jones, H., Gilks, B., Womack, C., Gourley, C., Ledermann, J., & Barrett, J. C. (2018). Candidate biomarkers of PARP inhibitor sensitivity in ovarian cancer beyond the BRCA genes. British Journal of Cancer, 119(11), 1401–1409. https://doi.org/10.1038/s41416-018-0274-8
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献